PI3K inhibitor TGX-221, Purity ≥98%

Cat. No.: X24-05-ZQ168

PI3K inhibitor TGX-221, Purity ≥98%

Synonym: 663619-89-4; TGX221; PI3K inhibitor

  • CAS Number: 663619-89-4
  • Compound CID: 9907093
Product Size
5 mg; 10mg; 25 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
TGX-221, soluble in DMSO and insoluble in ethanol and water, is a potent compound that inhibits PI3 kinase activity. It targets p110α, p110δ, Abl, C2α, CaMK, CaseinKinase2, CDK2/CyclinA, EGFR, ERK1, Fyn, and HER2.
Molecular Weight
364.4
Molecular Formula
C21H24N4O2
Targets
p110α: 5 μM; p110δ: 0.1 μM; Abl: >10 μM; C2α: >10 μM; CaMK: >10 μM; CaseinKinase2: >10 μM; CDK2/CyclinA: >10 μM; EGFR: >10 μM; ERK1: >10 μM; Fyn: >10 μM; HER2: >10 μM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 11 mg/mL (30.18 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
TGX-221 is utilized to investigate the inhibition of PI3Kβ and its implications in cancer and thrombosis research.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.